Trial intelligence / Profile preview

Ultrasound Guidance for Octreotide LAR in Acromegaly

NCT00552071Phase 4Completed

Sponsor
Cedars-Sinai Medical Center
Start
Jul 2007
Primary completion
Mar 2014
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of octreotide in acromegaly, sponsored by Cedars-Sinai Medical Center. Started Jul 2007; status: completed.

02

Drugs

octreotide
03

Conditions

acromegaly

Beyond the preview

Go deeper on NCT00552071.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00552071.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call